|
US4681102A
(en)
|
1985-09-11 |
1987-07-21 |
Bartell Michael T |
Apparatus and method for insertion of an intra-ocular lens
|
|
US4834750A
(en)
|
1987-09-17 |
1989-05-30 |
Ioptex Research, Inc. |
Deformable-elastic intraocular lens
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5290892A
(en)
|
1990-11-07 |
1994-03-01 |
Nestle S.A. |
Flexible intraocular lenses made from high refractive index polymers
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
US5443505A
(en)
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5554187A
(en)
|
1995-08-18 |
1996-09-10 |
Rizzo, Iii; Joseph |
Medication dispensing intra-ocular lens system
|
|
US20020164374A1
(en)
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
|
US6679605B2
(en)
|
2000-05-22 |
2004-01-20 |
Medennium, Inc. |
Crystalline polymeric compositions for ophthalmic devices
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1637126B1
(fr)
|
2000-07-05 |
2016-12-14 |
Allergan, Inc. |
Méthodes de traitement des inflammations de l'oeil
|
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
|
US6713081B2
(en)
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
GB2399753B
(en)
|
2002-01-18 |
2006-04-19 |
Michael E Snyder |
Method of making a sustained release ophthalmological device
|
|
US7655038B2
(en)
|
2003-02-28 |
2010-02-02 |
Biointeractions Ltd. |
Polymeric network system for medical devices and methods of use
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
CN101137338A
(zh)
*
|
2003-12-03 |
2008-03-05 |
眼睛光学技术公司 |
混合型可调节性人工晶状体
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
WO2005107708A1
(fr)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Implants d'inhibiteurs de tyrosine kinase intravitreens, biodegradables
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US20050244458A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
EP1611877A1
(fr)
|
2004-06-28 |
2006-01-04 |
Universidade de Coimbra |
Méthodes pour la préparation d'articles ophthalmiques thérapeutiques à la libération prolongée en utilisant des fluides compressés pour l'imprégnation des medicaments
|
|
US20060009498A1
(en)
|
2004-07-12 |
2006-01-12 |
Allergan, Inc. |
Ophthalmic compositions and methods for treating ophthalmic conditions
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
CA2637602C
(fr)
|
2006-01-17 |
2014-09-16 |
Forsight Labs, Llc |
Dispositif de traitement d'administration de medicament
|
|
US20070178138A1
(en)
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
US20090130176A1
(en)
*
|
2006-03-30 |
2009-05-21 |
Leila Bossy-Nobs |
Intraocular lens with drug delivery system attached thereto
|
|
JP4829345B2
(ja)
|
2006-05-04 |
2011-12-07 |
カフマン、ハーバート |
治療剤を眼球に投与するための方法、装置、およびシステム
|
|
US20070260203A1
(en)
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
CN101678038A
(zh)
|
2007-03-14 |
2010-03-24 |
华盛顿大学 |
用于眼内药物递送的装置和方法
|
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
US8138290B2
(en)
|
2008-01-25 |
2012-03-20 |
Bausch & Lomb Incorporated |
High water content ophthalmic devices
|
|
US8702794B2
(en)
|
2008-04-28 |
2014-04-22 |
Abbott Medical Optics Inc. |
Back loaded IOL insertion cartridge
|
|
US10588855B2
(en)
|
2008-05-12 |
2020-03-17 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
JP5591226B2
(ja)
|
2008-05-12 |
2014-09-17 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
眼内薬物送達装置および関連する方法
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
US8343214B2
(en)
|
2008-10-20 |
2013-01-01 |
Cateract Innovations LLC |
Apparatus for the treatment of cataract
|
|
US20120232649A1
(en)
*
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
|
US20110230963A1
(en)
|
2008-11-20 |
2011-09-22 |
Insight Innovations, Llc |
Biocompatible biodegradable intraocular implant system
|
|
CN103025312B
(zh)
*
|
2008-12-11 |
2016-08-10 |
麻省理工学院 |
接触透镜药物递送装置
|
|
EP4289416A3
(fr)
*
|
2009-05-18 |
2024-01-03 |
Dose Medical Corporation |
Implant oculaire à élution de médicament
|
|
EP4108216A1
(fr)
|
2009-06-03 |
2022-12-28 |
Forsight Vision5, Inc. |
Administration de médicaments de segment antérieur
|
|
BR112012010026B8
(pt)
|
2009-10-30 |
2021-02-02 |
Aton Pharma Inc |
método de formação de um dispositivo de liberação ocular e dispositivo de liberação ocular
|
|
EP2566468A4
(fr)
|
2010-05-03 |
2014-06-18 |
Massachusetts Inst Technology |
Revêtement de délivrance de médicaments et dispositifs
|
|
WO2011146483A1
(fr)
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Dispositifs d'administration de médicament pour administration d'agents thérapeutiques oculaires
|
|
EP2591026B1
(fr)
|
2010-07-05 |
2016-05-04 |
Dave, Jagrat Natavar |
Dispositif ophtalmique réfractif/diffractif et compositions utiles pour sa fabrication
|
|
US20130209538A1
(en)
|
2010-08-12 |
2013-08-15 |
Singapore Health Services Pte Ltd |
Biodegradable ocular implant
|
|
WO2012149278A1
(fr)
|
2011-04-29 |
2012-11-01 |
Allergan, Inc. |
Implant à base de latanoprost à libération soutenue
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
|
US20130302420A1
(en)
|
2012-05-14 |
2013-11-14 |
Barry L. Bowyer |
Ocular biodegradable drug implant and method of its use
|
|
US20150209274A1
(en)
*
|
2012-08-15 |
2015-07-30 |
Nanyang Technological University |
Drug eluting member, a method of attaching the same and a method of fabricating the same, a device for holding the same and a drug eluting device
|
|
ES2709351T3
(es)
|
2012-09-27 |
2019-04-16 |
Allergan Inc |
Sistemas de administración de fármacos biodegradables para la liberación sostenida de proteínas
|
|
US20150290170A1
(en)
|
2012-10-26 |
2015-10-15 |
Allergan, Inc. |
Ketorolac-containing sustained release drug delivery systems
|
|
US20150272877A1
(en)
|
2012-10-26 |
2015-10-01 |
Allergan, Inc. |
Ketorolac-containing sustained release drug delivery systems
|
|
US9750636B2
(en)
|
2012-10-26 |
2017-09-05 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
|
BR112015019546A2
(pt)
|
2013-02-15 |
2017-07-18 |
Allergan Inc |
implante de distribuição de drogas prolongado
|
|
CN109568672B
(zh)
|
2013-03-15 |
2022-06-24 |
阿勒根公司 |
含有前列腺胺的眼内植入物
|
|
WO2014179568A2
(fr)
|
2013-05-02 |
2014-11-06 |
Odin Biotech |
Implant oculaire à deux couches
|
|
US9492316B2
(en)
|
2013-10-31 |
2016-11-15 |
Allergan, Inc. |
Prostamide-containing intraocular implants and methods of use thereof
|
|
ES2864274T3
(es)
|
2013-11-14 |
2021-10-13 |
Eyed Pharma |
Dispositivo ocular
|
|
MX2016007345A
(es)
|
2013-12-06 |
2016-12-09 |
Envisia Therapeutics Inc |
Implante intracameral para el tratamiento de una condicion ocular.
|
|
EP3067015B1
(fr)
|
2015-03-10 |
2018-06-06 |
Consejo Superior De Investigaciones Científicas |
Engagement photochimiquement induit d'implants intraoculaires
|
|
EP3302382A4
(fr)
|
2015-05-29 |
2019-02-20 |
Allergan, Inc. |
Implant pour le traitement d'une affection oculaire
|
|
EP3324890A4
(fr)
|
2015-07-23 |
2019-06-19 |
Allergan, Inc. |
Traitement du glaucome oculaire par l'intermédiaire d'implants intracamérulaires
|
|
WO2017053686A1
(fr)
|
2015-09-24 |
2017-03-30 |
Massachusetts Eye And Ear Infirmary |
Système d'administration de médicament et procédés d'utilisation
|
|
GB201519811D0
(en)
|
2015-11-10 |
2015-12-23 |
Univ Belfast |
Ocular compositions
|
|
CN106729975B
(zh)
|
2015-11-19 |
2020-04-14 |
爱博诺德(北京)医疗科技股份有限公司 |
用于制造人工晶体的材料
|
|
CN106901871B
(zh)
*
|
2015-12-23 |
2021-08-24 |
爱博诺德(北京)医疗科技股份有限公司 |
具有一个或多个附加部分的人工晶状体
|
|
PT109154B
(pt)
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
|
EP3210572A1
(fr)
*
|
2016-02-29 |
2017-08-30 |
Elodie Jane Siney |
Lentille intraoculaire comprenant des microsphères contenant un médicament
|
|
JP7003110B2
(ja)
|
2016-04-20 |
2022-01-20 |
ドーズ メディカル コーポレーション |
生体吸収性眼球薬物送達デバイス
|
|
US10603274B2
(en)
|
2016-09-30 |
2020-03-31 |
Mati Therapeutics Inc. |
Ophthalmic drug sustained release formulation and uses thereof
|
|
EP3518897B1
(fr)
|
2016-09-30 |
2022-02-09 |
Mati Therapeutics Inc. |
Formulation ophtalmique à libération pharmacologique prolongée et ses utilisations
|
|
EP3562489A4
(fr)
|
2016-12-27 |
2020-07-29 |
University of Utah Research Foundation |
Dispositif d'administration de médicament intraoculaire et procédés associés
|
|
WO2018175268A1
(fr)
|
2017-03-19 |
2018-09-27 |
Biohealthways, Inc. |
Système d'administration oculaire de médicament à libération prolongée, implantable, à dégradation biologique
|
|
US11696952B2
(en)
|
2017-08-17 |
2023-07-11 |
Lutronic Vision Inc. |
Nanocapsule-based ocular therapy
|
|
CN107595765A
(zh)
|
2017-09-22 |
2018-01-19 |
沈阳兴齐眼药股份有限公司 |
一种眼用缓释药物递送系统及其制备方法
|
|
US20190192341A1
(en)
|
2017-11-09 |
2019-06-27 |
Allergan, Inc. |
Sustained-Release Implants for Lowering Intraocular Pressure with Extended Duration of Effect
|
|
CN112351755A
(zh)
|
2018-02-22 |
2021-02-09 |
伊万提斯公司 |
眼部植入物和输送系统
|
|
US20200069575A1
(en)
|
2018-08-30 |
2020-03-05 |
Yunxiang Liu |
Ophthalmic formulations, process for preparing the same and method for administering the same
|
|
DE102018129478B4
(de)
|
2018-11-22 |
2021-05-27 |
Carl Zeiss Meditec Ag |
Ophthalmologisches Implantat mit einem Wirkstoffabgabesystem und Verfahren zum Herstellen eines solchen ophthalmologischen Implantats
|
|
AU2019400857A1
(en)
|
2018-12-21 |
2021-08-12 |
Re-Vana Therapeutics Ltd |
Coated ocular implants
|
|
JP2022514773A
(ja)
|
2018-12-21 |
2022-02-15 |
レ‐ヴァーナ セラピューティクス エルティーディー |
眼用組成物
|
|
US20200281767A1
(en)
|
2019-03-10 |
2020-09-10 |
Paloza Llc |
Ocular agent delivery device, ocular monitoring device and methods thereof
|
|
US11039954B2
(en)
|
2019-03-21 |
2021-06-22 |
Microoptx Inc. |
Implantable ocular drug delivery devices and methods
|